Compare ESI & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESI | TECH |
|---|---|---|
| Founded | 1922 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 9.1B |
| IPO Year | 2014 | 1995 |
| Metric | ESI | TECH |
|---|---|---|
| Price | $36.05 | $72.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | $35.56 | ★ $71.82 |
| AVG Volume (30 Days) | ★ 6.6M | 5.2M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.75% | 0.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.23 | ★ 0.81 |
| Revenue | ★ $2,551,200,000.00 | $1,219,635,000.00 |
| Revenue This Year | $21.24 | $2.49 |
| Revenue Next Year | $7.34 | $6.40 |
| P/E Ratio | $164.52 | ★ $88.42 |
| Revenue Growth | 3.84 | ★ 5.23 |
| 52 Week Low | $22.63 | $43.20 |
| 52 Week High | $49.25 | $72.16 |
| Indicator | ESI | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 36.47 | 74.86 |
| Support Level | $25.19 | $70.49 |
| Resistance Level | $37.14 | $72.14 |
| Average True Range (ATR) | 1.60 | 0.38 |
| MACD | -0.24 | -0.66 |
| Stochastic Oscillator | 15.65 | 92.86 |
Element Solutions Inc is a specialty chemicals company whose businesses supply a broad range of solutions that enhance the performance of products people use every day. The company's reportable segments are Electronics and Industrial & Specialty. The Electronics segment, which generates maximum revenue, researches, formulates, and sells specialty chemicals and process technologies for all types of electronics hardware, from complex printed circuit board designs to semiconductor packaging. This segment's wet chemicals for metallization, surface treatments, and solderable finishes form the physical circuitry pathways, and its assembly materials, such as solder, pastes, fluxes, and adhesives, join those pathways together.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.